UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
(Rule 13d-102)
INFORMATION TO BE INCLUDED IN STATEMENTS
FILED PURSUANT TO RULE 13d-1(b), (c) AND (d)
AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2(b)
(Amendment No. __)*
CREATIVE VISTAS, INC.
(Name of Issuer)
Common Stock, no par value per share
(Title of Class of Securities)
225300201
(CUSIP Number)
January 23, 2008
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule
13G is filed:
[ ] Rule 13d-1(b)
[X] Rule 13d-1(c)
[ ] Rule 13d-1(d)
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
CUSIP No. 225300201
--------------------------------------------------------------------------------
(1) Names of Reporting Persons. I.R.S. Identification Nos. of Above Persons
(entities only):
Erato Corporation
57-1237862
--------------------------------------------------------------------------------
(2) Check the Appropriate Box if a Member of a Group (See Instructions)
(a) [ ]
(b) [X]
--------------------------------------------------------------------------------
(3) SEC Use Only
--------------------------------------------------------------------------------
(4) Citizenship or Place of Organization: Delaware
--------------------------------------------------------------------------------
Number of Shares Beneficially Owned
by Each Reporting Person With (5) Sole Voting Power: 0*
--------------------------------------
(6) Shared Voting Power: 3,665,365*
--------------------------------------
(7) Sole Dispositive Power: 0*
--------------------------------------
(8) Shared Dispositive Power: 3,665,365*
--------------------------------------
--------------------------------------------------------------------------------
(9) Aggregate Amount Beneficially Owned by Each Reporting Person:
3,665,365
--------------------------------------------------------------------------------
(10) Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See
Instructions): [X]
--------------------------------------------------------------------------------
(11) Percent of Class Represented by Amount in Row (9): 9.99%
--------------------------------------------------------------------------------
(12) Type of Reporting Person (See Instructions): CO
--------------------------------------------------------------------------------
|
*Based on 36,690,343 shares of the common stock, no par value per share (the
"Shares"), outstanding of Creative Vistas, Inc., an Arizona corporation (the
"Company"), as disclosed to Laurus Master Fund, Ltd. (the "Fund") by the
Company. As of January 23, 2008, the Fund, Erato Corporation ("Erato"), Valens
U.S. SPV I, LLC ("Valens U.S."), Valens Offshore SPV I, Ltd. ("Valens Offshore")
and PSource Structured Debt Limited ("PSource", and together with Erato, the
Fund, Valens U.S. and Valens Offshore, the "Investors", collectively held (i)
3,594,169 Shares, (ii) a common stock purchase warrant (the "January Warrant
#1") to acquire 812,988 Shares at an exercise price of $0.01 per Share, subject
to certain adjustments, (iii) a common stock purchase warrant (the "January
Warrant #2" and together with the January Warrant #1, the "January Warrants") to
acquire 1,738,365 Shares at an exercise price of $0.01 per Share, subject to
certain adjustments, (iv) a common stock purchase warrant (the "Other Warrant
#1") to acquire 108,000 Shares at an exercise price of $0.90 per Share, subject
to certain adjustments, (v) a common stock purchase warrant (the "Other Warrant
#2") to acquire 108,000 Shares at an exercise price of $1.15 per Share, subject
to certain adjustments, (vi) a common stock purchase warrant (the "Other Warrant
#3") to acquire 108,000 Shares at an exercise price of $1.25 per Share, subject
to certain adjustments, (vi) a common stock purchase warrant (the "Other Warrant
#4") to acquire 108,000 Shares at an exercise price of $2.28 per Share, subject
to certain adjustments, (vii) a common stock purchase warrant (the "Other
Warrant #5") to acquire 108,000 Shares at an exercise price of $2.10 per Share,
subject to certain adjustments, (viii) a common stock purchase warrant (the
"Other Warrant #6") to acquire 108,000 Shares at an exercise price of $2.55 per
Share, subject to certain adjustments, (ix) a common stock purchase warrant (the
"Other Warrant #7") to acquire 108,000 Shares at an exercise price of $2.73 per
Share, subject to certain adjustments, (x) a common stock purchase warrant (the
"Other Warrant #8") to acquire 108,000 Shares at an exercise price of $2.43 per
Share, subject to certain adjustments, (xi) a common stock purchase warrant (the
"Other Warrant #9") to acquire 139,800 Shares at an exercise price of $0.0067
per Share, subject to certain adjustments, (xii) a common stock purchase warrant
(the "Other Warrant #10") to acquire 1,094,636 Shares at an exercise price of
$1.15 per Share, subject to certain adjustments, (xiii) a common stock purchase
warrant (the "Other Warrant #11") to acquire 100,000 Shares at an exercise price
of $1.20 per Share, subject to certain adjustments, (xiv) a common stock
purchase warrant (the "Other Warrant #12") to acquire 100,000 Shares at an
exercise price of $1.01 per Share, subject to certain adjustments, (xv) a common
stock purchase warrant (the "Other Warrant #13") to acquire 313,000 Shares at an
exercise price of $1.00 per Share, subject to certain adjustments, (xvi) a
common stock purchase warrant (the "Other Warrant #15") to acquire 100,000
Shares at an exercise price of $0.90 per Share, subject to certain adjustments,
(xvii) a common stock purchase warrant (the "Other Warrant #16") to acquire
107,999 Shares at an exercise price of $2.60 per Share, subject to certain
adjustments, (xviii) a common stock purchase warrant (the "Other Warrant #17")
to acquire 107,999 Shares at an exercise price of $2.55 per Share, subject to
certain adjustments, and (xix) a common stock purchase warrant (the "Other
Warrant #18", and together with Other Warrant #1, Other Warrant #2, Other
Warrant #3, Other Warrant #4, Other Warrant #5, Other Warrant #6, Other Warrant
#7, Other Warrant #8, Other Warrant #9, Other Warrant #10, Other Warrant #11,
Other Warrant #12, Other Warrant #13, Other Warrant #14, Other Warrant #15,
Other Warrant #16 and Other Warrant #17, the "Other Warrants") to acquire
1,149,436 Shares at an exercise price of $0.01 per Share, subject to certain
adjustments). The January Warrants each contain an issuance limitation
prohibiting the Investors from exercising those securities to the extent that
such exercise would result in beneficial ownership by Erato of more than 9.99%
of the Shares then issued and outstanding (the "9.99% Issuance Limitation"). The
9.99% Issuance Limitation may be waived by the Investors by at least 61 days
notice, provided, however, that such notice shall only be effective if delivered
at a time when no indebtedness of the issuer is outstanding to the holder or its
affiliates and shall become null and void following notice to the issuer upon an
Event of Default (as defined in the relevant instrument). The Other Warrants
each contain an issuance limitation prohibiting the Investors from exercising
those securities to the extent that such exercise would result in beneficial
ownership by the Investors of more than 4.99% of the Shares then issued and
outstanding (the "4.99% Issuance Limitation"). The 4.99% Issuance Limitation may
be waived by the Investors upon at least 61 days prior notice to the Company and
shall automatically become null and void upon the occurrence and/or continuance
of an event of default (as defined in and pursuant to the terms of the
applicable instrument). Erato is a wholly owned subsidiary of the Fund. PSource
and the Fund are managed by Laurus Capital Management, LLC ("LCM"). Valens U.S.
and Valens Offshore are managed by Valens Capital Management, LLC ("VCM").
Eugene Grin and David Grin through other entities are the controlling principals
of LCM and VCM, and share voting and investment power over the securities owned
by the Investors reported in this Schedule 13G.
CUSIP No. 225300201
--------------------------------------------------------------------------------
(1) Names of Reporting Persons. I.R.S. Identification Nos. of Above Persons
(entities only):
Laurus Master Fund, Ltd.
98-0337673
--------------------------------------------------------------------------------
(2) Check the Appropriate Box if a Member of a Group (See Instructions)
(a) [ ]
(b) [X]
--------------------------------------------------------------------------------
(3) SEC Use Only
--------------------------------------------------------------------------------
(4) Citizenship or Place of Organization: Cayman Islands
--------------------------------------------------------------------------------
Number of Shares Beneficially Owned
by Each Reporting Person With (5) Sole Voting Power: 0*
--------------------------------------
(6) Shared Voting Power: 3,665,365*
--------------------------------------
(7) Sole Dispositive Power: 0*
--------------------------------------
(8) Shared Dispositive Power: 3,665,365*
--------------------------------------
--------------------------------------------------------------------------------
(9) Aggregate Amount Beneficially Owned by Each Reporting Person:
3,665,365
--------------------------------------------------------------------------------
(10) Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See
Instructions): [X]
--------------------------------------------------------------------------------
(11) Percent of Class Represented by Amount in Row (9): 9.99%
--------------------------------------------------------------------------------
(12) Type of Reporting Person (See Instructions): CO
--------------------------------------------------------------------------------
|
*Based on 36,690,343 shares of the common stock, no par value per share (the
"Shares"), outstanding of Creative Vistas, Inc., an Arizona corporation (the
"Company"), as disclosed to Laurus Master Fund, Ltd. (the "Fund") by the
Company. As of January 23, 2008, the Fund, Erato Corporation ("Erato"), Valens
U.S. SPV I, LLC ("Valens U.S."), Valens Offshore SPV I, Ltd. ("Valens Offshore")
and PSource Structured Debt Limited ("PSource", and together with Erato, the
Fund, Valens U.S. and Valens Offshore, the "Investors", collectively held (i)
3,594,169 Shares, (ii) a common stock purchase warrant (the "January Warrant
#1") to acquire 812,988 Shares at an exercise price of $0.01 per Share, subject
to certain adjustments, (iii) a common stock purchase warrant (the "January
Warrant #2" and together with the January Warrant #1, the "January Warrants") to
acquire 1,738,365 Shares at an exercise price of $0.01 per Share, subject to
certain adjustments, (iv) a common stock purchase warrant (the "Other Warrant
#1") to acquire 108,000 Shares at an exercise price of $0.90 per Share, subject
to certain adjustments, (v) a common stock purchase warrant (the "Other Warrant
#2") to acquire 108,000 Shares at an exercise price of $1.15 per Share, subject
to certain adjustments, (vi) a common stock purchase warrant (the "Other Warrant
#3") to acquire 108,000 Shares at an exercise price of $1.25 per Share, subject
to certain adjustments, (vi) a common stock purchase warrant (the "Other Warrant
#4") to acquire 108,000 Shares at an exercise price of $2.28 per Share, subject
to certain adjustments, (vii) a common stock purchase warrant (the "Other
Warrant #5") to acquire 108,000 Shares at an exercise price of $2.10 per Share,
subject to certain adjustments, (viii) a common stock purchase warrant (the
"Other Warrant #6") to acquire 108,000 Shares at an exercise price of $2.55 per
Share, subject to certain adjustments, (ix) a common stock purchase warrant (the
"Other Warrant #7") to acquire 108,000 Shares at an exercise price of $2.73 per
Share, subject to certain adjustments, (x) a common stock purchase warrant (the
"Other Warrant #8") to acquire 108,000 Shares at an exercise price of $2.43 per
Share, subject to certain adjustments, (xi) a common stock purchase warrant (the
"Other Warrant #9") to acquire 139,800 Shares at an exercise price of $0.0067
per Share, subject to certain adjustments, (xii) a common stock purchase warrant
(the "Other Warrant #10") to acquire 1,094,636 Shares at an exercise price of
$1.15 per Share, subject to certain adjustments, (xiii) a common stock purchase
warrant (the "Other Warrant #11") to acquire 100,000 Shares at an exercise price
of $1.20 per Share, subject to certain adjustments, (xiv) a common stock
purchase warrant (the "Other Warrant #12") to acquire 100,000 Shares at an
exercise price of $1.01 per Share, subject to certain adjustments, (xv) a common
stock purchase warrant (the "Other Warrant #13") to acquire 313,000 Shares at an
exercise price of $1.00 per Share, subject to certain adjustments, (xvi) a
common stock purchase warrant (the "Other Warrant #15") to acquire 100,000
Shares at an exercise price of $0.90 per Share, subject to certain adjustments,
(xvii) a common stock purchase warrant (the "Other Warrant #16") to acquire
107,999 Shares at an exercise price of $2.60 per Share, subject to certain
adjustments, (xviii) a common stock purchase warrant (the "Other Warrant #17")
to acquire 107,999 Shares at an exercise price of $2.55 per Share, subject to
certain adjustments, and (xix) a common stock purchase warrant (the "Other
Warrant #18", and together with Other Warrant #1, Other Warrant #2, Other
Warrant #3, Other Warrant #4, Other Warrant #5, Other Warrant #6, Other Warrant
#7, Other Warrant #8, Other Warrant #9, Other Warrant #10, Other Warrant #11,
Other Warrant #12, Other Warrant #13, Other Warrant #14, Other Warrant #15,
Other Warrant #16 and Other Warrant #17, the "Other Warrants") to acquire
1,149,436 Shares at an exercise price of $0.01 per Share, subject to certain
adjustments). The January Warrants each contain an issuance limitation
prohibiting the Investors from exercising those securities to the extent that
such exercise would result in beneficial ownership by Erato of more than 9.99%
of the Shares then issued and outstanding (the "9.99% Issuance Limitation"). The
9.99% Issuance Limitation may be waived by the Investors by at least 61 days
notice, provided, however, that such notice shall only be effective if delivered
at a time when no indebtedness of the issuer is outstanding to the holder or its
affiliates and shall become null and void following notice to the issuer upon an
Event of Default (as defined in the relevant instrument). The Other Warrants
each contain an issuance limitation prohibiting the Investors from exercising
those securities to the extent that such exercise would result in beneficial
ownership by the Investors of more than 4.99% of the Shares then issued and
outstanding (the "4.99% Issuance Limitation"). The 4.99% Issuance Limitation may
be waived by the Investors upon at least 61 days prior notice to the Company and
shall automatically become null and void upon the occurrence and/or continuance
of an event of default (as defined in and pursuant to the terms of the
applicable instrument). Erato is a wholly owned subsidiary of the Fund. PSource
and the Fund are managed by Laurus Capital Management, LLC ("LCM"). Valens U.S.
and Valens Offshore are managed by Valens Capital Management, LLC ("VCM").
Eugene Grin and David Grin through other entities are the controlling principals
of LCM and VCM, and share voting and investment power over the securities owned
by the Investors reported in this Schedule 13G.
CUSIP No. 225300201
--------------------------------------------------------------------------------
(1) Names of Reporting Persons. I.R.S. Identification Nos. of Above Persons
(entities only):
PSource Structured Debt Limited
98-0337673
--------------------------------------------------------------------------------
(2) Check the Appropriate Box if a Member of a Group (See Instructions)
(a) [ ]
(b) [X]
--------------------------------------------------------------------------------
(3) SEC Use Only
--------------------------------------------------------------------------------
(4) Citizenship or Place of Organization: Guernsey
--------------------------------------------------------------------------------
Number of Shares Beneficially Owned
by Each Reporting Person With (5) Sole Voting Power: 0*
--------------------------------------
(6) Shared Voting Power: 3,665,365*
--------------------------------------
(7) Sole Dispositive Power: 0*
--------------------------------------
(8) Shared Dispositive Power: 3,665,365*
--------------------------------------
--------------------------------------------------------------------------------
(9) Aggregate Amount Beneficially Owned by Each Reporting Person:
3,665,365
--------------------------------------------------------------------------------
(10) Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See
Instructions): [X]
--------------------------------------------------------------------------------
(11) Percent of Class Represented by Amount in Row (9): 9.99%
--------------------------------------------------------------------------------
(12) Type of Reporting Person (See Instructions): 0O
--------------------------------------------------------------------------------
|
*Based on 36,690,343 shares of the common stock, no par value per share (the
"Shares"), outstanding of Creative Vistas, Inc., an Arizona corporation (the
"Company"), as disclosed to Laurus Master Fund, Ltd. (the "Fund") by the
Company. As of January 23, 2008, the Fund, Erato Corporation ("Erato"), Valens
U.S. SPV I, LLC ("Valens U.S."), Valens Offshore SPV I, Ltd. ("Valens Offshore")
and PSource Structured Debt Limited ("PSource", and together with Erato, the
Fund, Valens U.S. and Valens Offshore, the "Investors", collectively held (i)
3,594,169 Shares, (ii) a common stock purchase warrant (the "January Warrant
#1") to acquire 812,988 Shares at an exercise price of $0.01 per Share, subject
to certain adjustments, (iii) a common stock purchase warrant (the "January
Warrant #2" and together with the January Warrant #1, the "January Warrants") to
acquire 1,738,365 Shares at an exercise price of $0.01 per Share, subject to
certain adjustments, (iv) a common stock purchase warrant (the "Other Warrant
#1") to acquire 108,000 Shares at an exercise price of $0.90 per Share, subject
to certain adjustments, (v) a common stock purchase warrant (the "Other Warrant
#2") to acquire 108,000 Shares at an exercise price of $1.15 per Share, subject
to certain adjustments, (vi) a common stock purchase warrant (the "Other Warrant
#3") to acquire 108,000 Shares at an exercise price of $1.25 per Share, subject
to certain adjustments, (vi) a common stock purchase warrant (the "Other Warrant
#4") to acquire 108,000 Shares at an exercise price of $2.28 per Share, subject
to certain adjustments, (vii) a common stock purchase warrant (the "Other
Warrant #5") to acquire 108,000 Shares at an exercise price of $2.10 per Share,
subject to certain adjustments, (viii) a common stock purchase warrant (the
"Other Warrant #6") to acquire 108,000 Shares at an exercise price of $2.55 per
Share, subject to certain adjustments, (ix) a common stock purchase warrant (the
"Other Warrant #7") to acquire 108,000 Shares at an exercise price of $2.73 per
Share, subject to certain adjustments, (x) a common stock purchase warrant (the
"Other Warrant #8") to acquire 108,000 Shares at an exercise price of $2.43 per
Share, subject to certain adjustments, (xi) a common stock purchase warrant (the
"Other Warrant #9") to acquire 139,800 Shares at an exercise price of $0.0067
per Share, subject to certain adjustments, (xii) a common stock purchase warrant
(the "Other Warrant #10") to acquire 1,094,636 Shares at an exercise price of
$1.15 per Share, subject to certain adjustments, (xiii) a common stock purchase
warrant (the "Other Warrant #11") to acquire 100,000 Shares at an exercise price
of $1.20 per Share, subject to certain adjustments, (xiv) a common stock
purchase warrant (the "Other Warrant #12") to acquire 100,000 Shares at an
exercise price of $1.01 per Share, subject to certain adjustments, (xv) a common
stock purchase warrant (the "Other Warrant #13") to acquire 313,000 Shares at an
exercise price of $1.00 per Share, subject to certain adjustments, (xvi) a
common stock purchase warrant (the "Other Warrant #15") to acquire 100,000
Shares at an exercise price of $0.90 per Share, subject to certain adjustments,
(xvii) a common stock purchase warrant (the "Other Warrant #16") to acquire
107,999 Shares at an exercise price of $2.60 per Share, subject to certain
adjustments, (xviii) a common stock purchase warrant (the "Other Warrant #17")
to acquire 107,999 Shares at an exercise price of $2.55 per Share, subject to
certain adjustments, and (xix) a common stock purchase warrant (the "Other
Warrant #18", and together with Other Warrant #1, Other Warrant #2, Other
Warrant #3, Other Warrant #4, Other Warrant #5, Other Warrant #6, Other Warrant
#7, Other Warrant #8, Other Warrant #9, Other Warrant #10, Other Warrant #11,
Other Warrant #12, Other Warrant #13, Other Warrant #14, Other Warrant #15,
Other Warrant #16 and Other Warrant #17, the "Other Warrants") to acquire
1,149,436 Shares at an exercise price of $0.01 per Share, subject to certain
adjustments). The January Warrants each contain an issuance limitation
prohibiting the Investors from exercising those securities to the extent that
such exercise would result in beneficial ownership by Erato of more than 9.99%
of the Shares then issued and outstanding (the "9.99% Issuance Limitation"). The
9.99% Issuance Limitation may be waived by the Investors by at least 61 days
notice, provided, however, that such notice shall only be effective if delivered
at a time when no indebtedness of the issuer is outstanding to the holder or its
affiliates and shall become null and void following notice to the issuer upon an
Event of Default (as defined in the relevant instrument). The Other Warrants
each contain an issuance limitation prohibiting the Investors from exercising
those securities to the extent that such exercise would result in beneficial
ownership by the Investors of more than 4.99% of the Shares then issued and
outstanding (the "4.99% Issuance Limitation"). The 4.99% Issuance Limitation may
be waived by the Investors upon at least 61 days prior notice to the Company and
shall automatically become null and void upon the occurrence and/or continuance
of an event of default (as defined in and pursuant to the terms of the
applicable instrument). Erato is a wholly owned subsidiary of the Fund. PSource
and the Fund are managed by Laurus Capital Management, LLC ("LCM"). Valens U.S.
and Valens Offshore are managed by Valens Capital Management, LLC ("VCM").
Eugene Grin and David Grin through other entities are the controlling principals
of LCM and VCM, and share voting and investment power over the securities owned
by the Investors reported in this Schedule 13G.
CUSIP No. 225300201
--------------------------------------------------------------------------------
(1) Names of Reporting Persons. I.R.S. Identification Nos. of Above Persons
(entities only):
Laurus Capital Management, LLC
13-4150669
--------------------------------------------------------------------------------
(2) Check the Appropriate Box if a Member of a Group (See Instructions)
(a) [ ]
(b) [X]
--------------------------------------------------------------------------------
(3) SEC Use Only
--------------------------------------------------------------------------------
(4) Citizenship or Place of Organization: Delaware
--------------------------------------------------------------------------------
Number of Shares Beneficially Owned
by Each Reporting Person With (5) Sole Voting Power: 0*
--------------------------------------
(6) Shared Voting Power: 3,665,365*
--------------------------------------
(7) Sole Dispositive Power: 0*
--------------------------------------
(8) Shared Dispositive Power: 3,665,365*
--------------------------------------
--------------------------------------------------------------------------------
(9) Aggregate Amount Beneficially Owned by Each Reporting Person:
3,665,365
--------------------------------------------------------------------------------
(10) Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See
Instructions): [X]
--------------------------------------------------------------------------------
(11) Percent of Class Represented by Amount in Row (9): 9.99%
--------------------------------------------------------------------------------
(12) Type of Reporting Person (See Instructions): OO
--------------------------------------------------------------------------------
|
*Based on 36,690,343 shares of the common stock, no par value per share (the
"Shares"), outstanding of Creative Vistas, Inc., an Arizona corporation (the
"Company"), as disclosed to Laurus Master Fund, Ltd. (the "Fund") by the
Company. As of January 23, 2008, the Fund, Erato Corporation ("Erato"), Valens
U.S. SPV I, LLC ("Valens U.S."), Valens Offshore SPV I, Ltd. ("Valens Offshore")
and PSource Structured Debt Limited ("PSource", and together with Erato, the
Fund, Valens U.S. and Valens Offshore, the "Investors", collectively held (i)
3,594,169 Shares, (ii) a common stock purchase warrant (the "January Warrant
#1") to acquire 812,988 Shares at an exercise price of $0.01 per Share, subject
to certain adjustments, (iii) a common stock purchase warrant (the "January
Warrant #2" and together with the January Warrant #1, the "January Warrants") to
acquire 1,738,365 Shares at an exercise price of $0.01 per Share, subject to
certain adjustments, (iv) a common stock purchase warrant (the "Other Warrant
#1") to acquire 108,000 Shares at an exercise price of $0.90 per Share, subject
to certain adjustments, (v) a common stock purchase warrant (the "Other Warrant
#2") to acquire 108,000 Shares at an exercise price of $1.15 per Share, subject
to certain adjustments, (vi) a common stock purchase warrant (the "Other Warrant
#3") to acquire 108,000 Shares at an exercise price of $1.25 per Share, subject
to certain adjustments, (vi) a common stock purchase warrant (the "Other Warrant
#4") to acquire 108,000 Shares at an exercise price of $2.28 per Share, subject
to certain adjustments, (vii) a common stock purchase warrant (the "Other
Warrant #5") to acquire 108,000 Shares at an exercise price of $2.10 per Share,
subject to certain adjustments, (viii) a common stock purchase warrant (the
"Other Warrant #6") to acquire 108,000 Shares at an exercise price of $2.55 per
Share, subject to certain adjustments, (ix) a common stock purchase warrant (the
"Other Warrant #7") to acquire 108,000 Shares at an exercise price of $2.73 per
Share, subject to certain adjustments, (x) a common stock purchase warrant (the
"Other Warrant #8") to acquire 108,000 Shares at an exercise price of $2.43 per
Share, subject to certain adjustments, (xi) a common stock purchase warrant (the
"Other Warrant #9") to acquire 139,800 Shares at an exercise price of $0.0067
per Share, subject to certain adjustments, (xii) a common stock purchase warrant
(the "Other Warrant #10") to acquire 1,094,636 Shares at an exercise price of
$1.15 per Share, subject to certain adjustments, (xiii) a common stock purchase
warrant (the "Other Warrant #11") to acquire 100,000 Shares at an exercise price
of $1.20 per Share, subject to certain adjustments, (xiv) a common stock
purchase warrant (the "Other Warrant #12") to acquire 100,000 Shares at an
exercise price of $1.01 per Share, subject to certain adjustments, (xv) a common
stock purchase warrant (the "Other Warrant #13") to acquire 313,000 Shares at an
exercise price of $1.00 per Share, subject to certain adjustments, (xvi) a
common stock purchase warrant (the "Other Warrant #15") to acquire 100,000
Shares at an exercise price of $0.90 per Share, subject to certain adjustments,
(xvii) a common stock purchase warrant (the "Other Warrant #16") to acquire
107,999 Shares at an exercise price of $2.60 per Share, subject to certain
adjustments, (xviii) a common stock purchase warrant (the "Other Warrant #17")
to acquire 107,999 Shares at an exercise price of $2.55 per Share, subject to
certain adjustments, and (xix) a common stock purchase warrant (the "Other
Warrant #18", and together with Other Warrant #1, Other Warrant #2, Other
Warrant #3, Other Warrant #4, Other Warrant #5, Other Warrant #6, Other Warrant
#7, Other Warrant #8, Other Warrant #9, Other Warrant #10, Other Warrant #11,
Other Warrant #12, Other Warrant #13, Other Warrant #14, Other Warrant #15,
Other Warrant #16 and Other Warrant #17, the "Other Warrants") to acquire
1,149,436 Shares at an exercise price of $0.01 per Share, subject to certain
adjustments). The January Warrants each contain an issuance limitation
prohibiting the Investors from exercising those securities to the extent that
such exercise would result in beneficial ownership by Erato of more than 9.99%
of the Shares then issued and outstanding (the "9.99% Issuance Limitation"). The
9.99% Issuance Limitation may be waived by the Investors by at least 61 days
notice, provided, however, that such notice shall only be effective if delivered
at a time when no indebtedness of the issuer is outstanding to the holder or its
affiliates and shall become null and void following notice to the issuer upon an
Event of Default (as defined in the relevant instrument). The Other Warrants
each contain an issuance limitation prohibiting the Investors from exercising
those securities to the extent that such exercise would result in beneficial
ownership by the Investors of more than 4.99% of the Shares then issued and
outstanding (the "4.99% Issuance Limitation"). The 4.99% Issuance Limitation may
be waived by the Investors upon at least 61 days prior notice to the Company and
shall automatically become null and void upon the occurrence and/or continuance
of an event of default (as defined in and pursuant to the terms of the
applicable instrument). Erato is a wholly owned subsidiary of the Fund. PSource
and the Fund are managed by Laurus Capital Management, LLC ("LCM"). Valens U.S.
and Valens Offshore are managed by Valens Capital Management, LLC ("VCM").
Eugene Grin and David Grin through other entities are the controlling principals
of LCM and VCM, and share voting and investment power over the securities owned
by the Investors reported in this Schedule 13G.
CUSIP No. 225300201
--------------------------------------------------------------------------------
(1) Names of Reporting Persons. I.R.S. Identification Nos. of Above Persons
(entities only):
Valens U.S. SPV I, LLC
20-8903266
--------------------------------------------------------------------------------
(2) Check the Appropriate Box if a Member of a Group (See Instructions)
(a) [ ]
(b) [X]
--------------------------------------------------------------------------------
(3) SEC Use Only
--------------------------------------------------------------------------------
(4) Citizenship or Place of Organization: Delaware
--------------------------------------------------------------------------------
Number of Shares Beneficially Owned
by Each Reporting Person With (5) Sole Voting Power: 0*
--------------------------------------
(6) Shared Voting Power: 3,665,365*
--------------------------------------
(7) Sole Dispositive Power: 0*
--------------------------------------
(8) Shared Dispositive Power: 3,665,365*
--------------------------------------
--------------------------------------------------------------------------------
(9) Aggregate Amount Beneficially Owned by Each Reporting Person:
3,665,365
--------------------------------------------------------------------------------
(10) Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See
Instructions): [X]
--------------------------------------------------------------------------------
(11) Percent of Class Represented by Amount in Row (9): 9.99%
--------------------------------------------------------------------------------
(12) Type of Reporting Person (See Instructions): OO
--------------------------------------------------------------------------------
|
*Based on 36,690,343 shares of the common stock, no par value per share (the
"Shares"), outstanding of Creative Vistas, Inc., an Arizona corporation (the
"Company"), as disclosed to Laurus Master Fund, Ltd. (the "Fund") by the
Company. As of January 23, 2008, the Fund, Erato Corporation ("Erato"), Valens
U.S. SPV I, LLC ("Valens U.S."), Valens Offshore SPV I, Ltd. ("Valens Offshore")
and PSource Structured Debt Limited ("PSource", and together with Erato, the
Fund, Valens U.S. and Valens Offshore, the "Investors", collectively held (i)
3,594,169 Shares, (ii) a common stock purchase warrant (the "January Warrant
#1") to acquire 812,988 Shares at an exercise price of $0.01 per Share, subject
to certain adjustments, (iii) a common stock purchase warrant (the "January
Warrant #2" and together with the January Warrant #1, the "January Warrants") to
acquire 1,738,365 Shares at an exercise price of $0.01 per Share, subject to
certain adjustments, (iv) a common stock purchase warrant (the "Other Warrant
#1") to acquire 108,000 Shares at an exercise price of $0.90 per Share, subject
to certain adjustments, (v) a common stock purchase warrant (the "Other Warrant
#2") to acquire 108,000 Shares at an exercise price of $1.15 per Share, subject
to certain adjustments, (vi) a common stock purchase warrant (the "Other Warrant
#3") to acquire 108,000 Shares at an exercise price of $1.25 per Share, subject
to certain adjustments, (vi) a common stock purchase warrant (the "Other Warrant
#4") to acquire 108,000 Shares at an exercise price of $2.28 per Share, subject
to certain adjustments, (vii) a common stock purchase warrant (the "Other
Warrant #5") to acquire 108,000 Shares at an exercise price of $2.10 per Share,
subject to certain adjustments, (viii) a common stock purchase warrant (the
"Other Warrant #6") to acquire 108,000 Shares at an exercise price of $2.55 per
Share, subject to certain adjustments, (ix) a common stock purchase warrant (the
"Other Warrant #7") to acquire 108,000 Shares at an exercise price of $2.73 per
Share, subject to certain adjustments, (x) a common stock purchase warrant (the
"Other Warrant #8") to acquire 108,000 Shares at an exercise price of $2.43 per
Share, subject to certain adjustments, (xi) a common stock purchase warrant (the
"Other Warrant #9") to acquire 139,800 Shares at an exercise price of $0.0067
per Share, subject to certain adjustments, (xii) a common stock purchase warrant
(the "Other Warrant #10") to acquire 1,094,636 Shares at an exercise price of
$1.15 per Share, subject to certain adjustments, (xiii) a common stock purchase
warrant (the "Other Warrant #11") to acquire 100,000 Shares at an exercise price
of $1.20 per Share, subject to certain adjustments, (xiv) a common stock
purchase warrant (the "Other Warrant #12") to acquire 100,000 Shares at an
exercise price of $1.01 per Share, subject to certain adjustments, (xv) a common
stock purchase warrant (the "Other Warrant #13") to acquire 313,000 Shares at an
exercise price of $1.00 per Share, subject to certain adjustments, (xvi) a
common stock purchase warrant (the "Other Warrant #15") to acquire 100,000
Shares at an exercise price of $0.90 per Share, subject to certain adjustments,
(xvii) a common stock purchase warrant (the "Other Warrant #16") to acquire
107,999 Shares at an exercise price of $2.60 per Share, subject to certain
adjustments, (xviii) a common stock purchase warrant (the "Other Warrant #17")
to acquire 107,999 Shares at an exercise price of $2.55 per Share, subject to
certain adjustments, and (xix) a common stock purchase warrant (the "Other
Warrant #18", and together with Other Warrant #1, Other Warrant #2, Other
Warrant #3, Other Warrant #4, Other Warrant #5, Other Warrant #6, Other Warrant
#7, Other Warrant #8, Other Warrant #9, Other Warrant #10, Other Warrant #11,
Other Warrant #12, Other Warrant #13, Other Warrant #14, Other Warrant #15,
Other Warrant #16 and Other Warrant #17, the "Other Warrants") to acquire
1,149,436 Shares at an exercise price of $0.01 per Share, subject to certain
adjustments). The January Warrants each contain an issuance limitation
prohibiting the Investors from exercising those securities to the extent that
such exercise would result in beneficial ownership by Erato of more than 9.99%
of the Shares then issued and outstanding (the "9.99% Issuance Limitation"). The
9.99% Issuance Limitation may be waived by the Investors by at least 61 days
notice, provided, however, that such notice shall only be effective if delivered
at a time when no indebtedness of the issuer is outstanding to the holder or its
affiliates and shall become null and void following notice to the issuer upon an
Event of Default (as defined in the relevant instrument). The Other Warrants
each contain an issuance limitation prohibiting the Investors from exercising
those securities to the extent that such exercise would result in beneficial
ownership by the Investors of more than 4.99% of the Shares then issued and
outstanding (the "4.99% Issuance Limitation"). The 4.99% Issuance Limitation may
be waived by the Investors upon at least 61 days prior notice to the Company and
shall automatically become null and void upon the occurrence and/or continuance
of an event of default (as defined in and pursuant to the terms of the
applicable instrument). Erato is a wholly owned subsidiary of the Fund. PSource
and the Fund are managed by Laurus Capital Management, LLC ("LCM"). Valens U.S.
and Valens Offshore are managed by Valens Capital Management, LLC ("VCM").
Eugene Grin and David Grin through other entities are the controlling principals
of LCM and VCM, and share voting and investment power over the securities owned
by the Investors reported in this Schedule 13G.
CUSIP No. 225300201
--------------------------------------------------------------------------------
(1) Names of Reporting Persons. I.R.S. Identification Nos. of Above Persons
(entities only):
Valens Offshore SPV I, Ltd.
98-0539781
--------------------------------------------------------------------------------
(2) Check the Appropriate Box if a Member of a Group (See Instructions)
(a) [ ]
(b) [X]
--------------------------------------------------------------------------------
(3) SEC Use Only
--------------------------------------------------------------------------------
(4) Citizenship or Place of Organization: Cayman Islands
--------------------------------------------------------------------------------
Number of Shares Beneficially Owned
by Each Reporting Person With (5) Sole Voting Power: 0*
--------------------------------------
(6) Shared Voting Power: 3,665,365*
--------------------------------------
(7) Sole Dispositive Power: 0*
--------------------------------------
(8) Shared Dispositive Power: 3,665,365*
--------------------------------------
--------------------------------------------------------------------------------
(9) Aggregate Amount Beneficially Owned by Each Reporting Person:
3,665,365
--------------------------------------------------------------------------------
(10) Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See
Instructions): [X]
--------------------------------------------------------------------------------
(11) Percent of Class Represented by Amount in Row (9): 9.99%
--------------------------------------------------------------------------------
(12) Type of Reporting Person (See Instructions): OO
--------------------------------------------------------------------------------
|
*Based on 36,690,343 shares of the common stock, no par value per share (the
"Shares"), outstanding of Creative Vistas, Inc., an Arizona corporation (the
"Company"), as disclosed to Laurus Master Fund, Ltd. (the "Fund") by the
Company. As of January 23, 2008, the Fund, Erato Corporation ("Erato"), Valens
U.S. SPV I, LLC ("Valens U.S."), Valens Offshore SPV I, Ltd. ("Valens Offshore")
and PSource Structured Debt Limited ("PSource", and together with Erato, the
Fund, Valens U.S. and Valens Offshore, the "Investors", collectively held (i)
3,594,169 Shares, (ii) a common stock purchase warrant (the "January Warrant
#1") to acquire 812,988 Shares at an exercise price of $0.01 per Share, subject
to certain adjustments, (iii) a common stock purchase warrant (the "January
Warrant #2" and together with the January Warrant #1, the "January Warrants") to
acquire 1,738,365 Shares at an exercise price of $0.01 per Share, subject to
certain adjustments, (iv) a common stock purchase warrant (the "Other Warrant
#1") to acquire 108,000 Shares at an exercise price of $0.90 per Share, subject
to certain adjustments, (v) a common stock purchase warrant (the "Other Warrant
#2") to acquire 108,000 Shares at an exercise price of $1.15 per Share, subject
to certain adjustments, (vi) a common stock purchase warrant (the "Other Warrant
#3") to acquire 108,000 Shares at an exercise price of $1.25 per Share, subject
to certain adjustments, (vi) a common stock purchase warrant (the "Other Warrant
#4") to acquire 108,000 Shares at an exercise price of $2.28 per Share, subject
to certain adjustments, (vii) a common stock purchase warrant (the "Other
Warrant #5") to acquire 108,000 Shares at an exercise price of $2.10 per Share,
subject to certain adjustments, (viii) a common stock purchase warrant (the
"Other Warrant #6") to acquire 108,000 Shares at an exercise price of $2.55 per
Share, subject to certain adjustments, (ix) a common stock purchase warrant (the
"Other Warrant #7") to acquire 108,000 Shares at an exercise price of $2.73 per
Share, subject to certain adjustments, (x) a common stock purchase warrant (the
"Other Warrant #8") to acquire 108,000 Shares at an exercise price of $2.43 per
Share, subject to certain adjustments, (xi) a common stock purchase warrant (the
"Other Warrant #9") to acquire 139,800 Shares at an exercise price of $0.0067
per Share, subject to certain adjustments, (xii) a common stock purchase warrant
(the "Other Warrant #10") to acquire 1,094,636 Shares at an exercise price of
$1.15 per Share, subject to certain adjustments, (xiii) a common stock purchase
warrant (the "Other Warrant #11") to acquire 100,000 Shares at an exercise price
of $1.20 per Share, subject to certain adjustments, (xiv) a common stock
purchase warrant (the "Other Warrant #12") to acquire 100,000 Shares at an
exercise price of $1.01 per Share, subject to certain adjustments, (xv) a common
stock purchase warrant (the "Other Warrant #13") to acquire 313,000 Shares at an
exercise price of $1.00 per Share, subject to certain adjustments, (xvi) a
common stock purchase warrant (the "Other Warrant #15") to acquire 100,000
Shares at an exercise price of $0.90 per Share, subject to certain adjustments,
(xvii) a common stock purchase warrant (the "Other Warrant #16") to acquire
107,999 Shares at an exercise price of $2.60 per Share, subject to certain
adjustments, (xviii) a common stock purchase warrant (the "Other Warrant #17")
to acquire 107,999 Shares at an exercise price of $2.55 per Share, subject to
certain adjustments, and (xix) a common stock purchase warrant (the "Other
Warrant #18", and together with Other Warrant #1, Other Warrant #2, Other
Warrant #3, Other Warrant #4, Other Warrant #5, Other Warrant #6, Other Warrant
#7, Other Warrant #8, Other Warrant #9, Other Warrant #10, Other Warrant #11,
Other Warrant #12, Other Warrant #13, Other Warrant #14, Other Warrant #15,
Other Warrant #16 and Other Warrant #17, the "Other Warrants") to acquire
1,149,436 Shares at an exercise price of $0.01 per Share, subject to certain
adjustments). The January Warrants each contain an issuance limitation
prohibiting the Investors from exercising those securities to the extent that
such exercise would result in beneficial ownership by Erato of more than 9.99%
of the Shares then issued and outstanding (the "9.99% Issuance Limitation"). The
9.99% Issuance Limitation may be waived by the Investors by at least 61 days
notice, provided, however, that such notice shall only be effective if delivered
at a time when no indebtedness of the issuer is outstanding to the holder or its
affiliates and shall become null and void following notice to the issuer upon an
Event of Default (as defined in the relevant instrument). The Other Warrants
each contain an issuance limitation prohibiting the Investors from exercising
those securities to the extent that such exercise would result in beneficial
ownership by the Investors of more than 4.99% of the Shares then issued and
outstanding (the "4.99% Issuance Limitation"). The 4.99% Issuance Limitation may
be waived by the Investors upon at least 61 days prior notice to the Company and
shall automatically become null and void upon the occurrence and/or continuance
of an event of default (as defined in and pursuant to the terms of the
applicable instrument). Erato is a wholly owned subsidiary of the Fund. PSource
and the Fund are managed by Laurus Capital Management, LLC ("LCM"). Valens U.S.
and Valens Offshore are managed by Valens Capital Management, LLC ("VCM").
Eugene Grin and David Grin through other entities are the controlling principals
of LCM and VCM, and share voting and investment power over the securities owned
by the Investors reported in this Schedule 13G.
CUSIP No. 225300201
--------------------------------------------------------------------------------
(1) Names of Reporting Persons. I.R.S. Identification Nos. of Above Persons
(entities only):
Valens Capital Management, LLC
20-8903345
--------------------------------------------------------------------------------
(2) Check the Appropriate Box if a Member of a Group (See Instructions)
(a) [ ]
(b) [X]
--------------------------------------------------------------------------------
(3) SEC Use Only
--------------------------------------------------------------------------------
(4) Citizenship or Place of Organization: Cayman Islands
--------------------------------------------------------------------------------
Number of Shares Beneficially Owned
by Each Reporting Person With (5) Sole Voting Power: 0*
--------------------------------------
(6) Shared Voting Power: 3,665,365*
--------------------------------------
(7) Sole Dispositive Power: 0*
--------------------------------------
(8) Shared Dispositive Power: 3,665,365*
--------------------------------------
--------------------------------------------------------------------------------
(9) Aggregate Amount Beneficially Owned by Each Reporting Person:
3,665,365
--------------------------------------------------------------------------------
(10) Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See
Instructions): [X]
--------------------------------------------------------------------------------
(11) Percent of Class Represented by Amount in Row (9): 9.99%
--------------------------------------------------------------------------------
(12) Type of Reporting Person (See Instructions): OO
--------------------------------------------------------------------------------
|
*Based on 36,690,343 shares of the common stock, no par value per share (the
"Shares"), outstanding of Creative Vistas, Inc., an Arizona corporation (the
"Company"), as disclosed to Laurus Master Fund, Ltd. (the "Fund") by the
Company. As of January 23, 2008, the Fund, Erato Corporation ("Erato"), Valens
U.S. SPV I, LLC ("Valens U.S."), Valens Offshore SPV I, Ltd. ("Valens Offshore")
and PSource Structured Debt Limited ("PSource", and together with Erato, the
Fund, Valens U.S. and Valens Offshore, the "Investors", collectively held (i)
3,594,169 Shares, (ii) a common stock purchase warrant (the "January Warrant
#1") to acquire 812,988 Shares at an exercise price of $0.01 per Share, subject
to certain adjustments, (iii) a common stock purchase warrant (the "January
Warrant #2" and together with the January Warrant #1, the "January Warrants") to
acquire 1,738,365 Shares at an exercise price of $0.01 per Share, subject to
certain adjustments, (iv) a common stock purchase warrant (the "Other Warrant
#1") to acquire 108,000 Shares at an exercise price of $0.90 per Share, subject
to certain adjustments, (v) a common stock purchase warrant (the "Other Warrant
#2") to acquire 108,000 Shares at an exercise price of $1.15 per Share, subject
to certain adjustments, (vi) a common stock purchase warrant (the "Other Warrant
#3") to acquire 108,000 Shares at an exercise price of $1.25 per Share, subject
to certain adjustments, (vi) a common stock purchase warrant (the "Other Warrant
#4") to acquire 108,000 Shares at an exercise price of $2.28 per Share, subject
to certain adjustments, (vii) a common stock purchase warrant (the "Other
Warrant #5") to acquire 108,000 Shares at an exercise price of $2.10 per Share,
subject to certain adjustments, (viii) a common stock purchase warrant (the
"Other Warrant #6") to acquire 108,000 Shares at an exercise price of $2.55 per
Share, subject to certain adjustments, (ix) a common stock purchase warrant (the
"Other Warrant #7") to acquire 108,000 Shares at an exercise price of $2.73 per
Share, subject to certain adjustments, (x) a common stock purchase warrant (the
"Other Warrant #8") to acquire 108,000 Shares at an exercise price of $2.43 per
Share, subject to certain adjustments, (xi) a common stock purchase warrant (the
"Other Warrant #9") to acquire 139,800 Shares at an exercise price of $0.0067
per Share, subject to certain adjustments, (xii) a common stock purchase warrant
(the "Other Warrant #10") to acquire 1,094,636 Shares at an exercise price of
$1.15 per Share, subject to certain adjustments, (xiii) a common stock purchase
warrant (the "Other Warrant #11") to acquire 100,000 Shares at an exercise price
of $1.20 per Share, subject to certain adjustments, (xiv) a common stock
purchase warrant (the "Other Warrant #12") to acquire 100,000 Shares at an
exercise price of $1.01 per Share, subject to certain adjustments, (xv) a common
stock purchase warrant (the "Other Warrant #13") to acquire 313,000 Shares at an
exercise price of $1.00 per Share, subject to certain adjustments, (xvi) a
common stock purchase warrant (the "Other Warrant #15") to acquire 100,000
Shares at an exercise price of $0.90 per Share, subject to certain adjustments,
(xvii) a common stock purchase warrant (the "Other Warrant #16") to acquire
107,999 Shares at an exercise price of $2.60 per Share, subject to certain
adjustments, (xviii) a common stock purchase warrant (the "Other Warrant #17")
to acquire 107,999 Shares at an exercise price of $2.55 per Share, subject to
certain adjustments, and (xix) a common stock purchase warrant (the "Other
Warrant #18", and together with Other Warrant #1, Other Warrant #2, Other
Warrant #3, Other Warrant #4, Other Warrant #5, Other Warrant #6, Other Warrant
#7, Other Warrant #8, Other Warrant #9, Other Warrant #10, Other Warrant #11,
Other Warrant #12, Other Warrant #13, Other Warrant #14, Other Warrant #15,
Other Warrant #16 and Other Warrant #17, the "Other Warrants") to acquire
1,149,436 Shares at an exercise price of $0.01 per Share, subject to certain
adjustments). The January Warrants each contain an issuance limitation
prohibiting the Investors from exercising those securities to the extent that
such exercise would result in beneficial ownership by Erato of more than 9.99%
of the Shares then issued and outstanding (the "9.99% Issuance Limitation"). The
9.99% Issuance Limitation may be waived by the Investors by at least 61 days
notice, provided, however, that such notice shall only be effective if delivered
at a time when no indebtedness of the issuer is outstanding to the holder or its
affiliates and shall become null and void following notice to the issuer upon an
Event of Default (as defined in the relevant instrument). The Other Warrants
each contain an issuance limitation prohibiting the Investors from exercising
those securities to the extent that such exercise would result in beneficial
ownership by the Investors of more than 4.99% of the Shares then issued and
outstanding (the "4.99% Issuance Limitation"). The 4.99% Issuance Limitation may
be waived by the Investors upon at least 61 days prior notice to the Company and
shall automatically become null and void upon the occurrence and/or continuance
of an event of default (as defined in and pursuant to the terms of the
applicable instrument). Erato is a wholly owned subsidiary of the Fund. PSource
and the Fund are managed by Laurus Capital Management, LLC ("LCM"). Valens U.S.
and Valens Offshore are managed by Valens Capital Management, LLC ("VCM").
Eugene Grin and David Grin through other entities are the controlling principals
of LCM and VCM, and share voting and investment power over the securities owned
by the Investors reported in this Schedule 13G.
CUSIP No. 225300201
--------------------------------------------------------------------------------
(1) Names of Reporting Persons. I.R.S. Identification Nos. of Above Persons
(entities only):
David Grin
--------------------------------------------------------------------------------
(2) Check the Appropriate Box if a Member of a Group (See Instructions)
(a) [ ]
(b) [X]
--------------------------------------------------------------------------------
(3) SEC Use Only
--------------------------------------------------------------------------------
(4) Citizenship or Place of Organization: Israel
--------------------------------------------------------------------------------
Number of Shares Beneficially Owned
by Each Reporting Person With (5) Sole Voting Power: 0*
--------------------------------------
(6) Shared Voting Power: 3,665,365*
--------------------------------------
(7) Sole Dispositive Power: 0*
--------------------------------------
(8) Shared Dispositive Power: 3,665,365*
--------------------------------------
--------------------------------------------------------------------------------
(9) Aggregate Amount Beneficially Owned by Each Reporting Person:
3,665,365
--------------------------------------------------------------------------------
(10) Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See
Instructions): [X]
--------------------------------------------------------------------------------
(11) Percent of Class Represented by Amount in Row (9): 9.99%
--------------------------------------------------------------------------------
(12) Type of Reporting Person (See Instructions): IN
--------------------------------------------------------------------------------
|
*Based on 36,690,343 shares of the common stock, no par value per share (the
"Shares"), outstanding of Creative Vistas, Inc., an Arizona corporation (the
"Company"), as disclosed to Laurus Master Fund, Ltd. (the "Fund") by the
Company. As of January 23, 2008, the Fund, Erato Corporation ("Erato"), Valens
U.S. SPV I, LLC ("Valens U.S."), Valens Offshore SPV I, Ltd. ("Valens Offshore")
and PSource Structured Debt Limited ("PSource", and together with Erato, the
Fund, Valens U.S. and Valens Offshore, the "Investors", collectively held (i)
3,594,169 Shares, (ii) a common stock purchase warrant (the "January Warrant
#1") to acquire 812,988 Shares at an exercise price of $0.01 per Share, subject
to certain adjustments, (iii) a common stock purchase warrant (the "January
Warrant #2" and together with the January Warrant #1, the "January Warrants") to
acquire 1,738,365 Shares at an exercise price of $0.01 per Share, subject to
certain adjustments, (iv) a common stock purchase warrant (the "Other Warrant
#1") to acquire 108,000 Shares at an exercise price of $0.90 per Share, subject
to certain adjustments, (v) a common stock purchase warrant (the "Other Warrant
#2") to acquire 108,000 Shares at an exercise price of $1.15 per Share, subject
to certain adjustments, (vi) a common stock purchase warrant (the "Other Warrant
#3") to acquire 108,000 Shares at an exercise price of $1.25 per Share, subject
to certain adjustments, (vi) a common stock purchase warrant (the "Other Warrant
#4") to acquire 108,000 Shares at an exercise price of $2.28 per Share, subject
to certain adjustments, (vii) a common stock purchase warrant (the "Other
Warrant #5") to acquire 108,000 Shares at an exercise price of $2.10 per Share,
subject to certain adjustments, (viii) a common stock purchase warrant (the
"Other Warrant #6") to acquire 108,000 Shares at an exercise price of $2.55 per
Share, subject to certain adjustments, (ix) a common stock purchase warrant (the
"Other Warrant #7") to acquire 108,000 Shares at an exercise price of $2.73 per
Share, subject to certain adjustments, (x) a common stock purchase warrant (the
"Other Warrant #8") to acquire 108,000 Shares at an exercise price of $2.43 per
Share, subject to certain adjustments, (xi) a common stock purchase warrant (the
"Other Warrant #9") to acquire 139,800 Shares at an exercise price of $0.0067
per Share, subject to certain adjustments, (xii) a common stock purchase warrant
(the "Other Warrant #10") to acquire 1,094,636 Shares at an exercise price of
$1.15 per Share, subject to certain adjustments, (xiii) a common stock purchase
warrant (the "Other Warrant #11") to acquire 100,000 Shares at an exercise price
of $1.20 per Share, subject to certain adjustments, (xiv) a common stock
purchase warrant (the "Other Warrant #12") to acquire 100,000 Shares at an
exercise price of $1.01 per Share, subject to certain adjustments, (xv) a common
stock purchase warrant (the "Other Warrant #13") to acquire 313,000 Shares at an
exercise price of $1.00 per Share, subject to certain adjustments, (xvi) a
common stock purchase warrant (the "Other Warrant #15") to acquire 100,000
Shares at an exercise price of $0.90 per Share, subject to certain adjustments,
(xvii) a common stock purchase warrant (the "Other Warrant #16") to acquire
107,999 Shares at an exercise price of $2.60 per Share, subject to certain
adjustments, (xviii) a common stock purchase warrant (the "Other Warrant #17")
to acquire 107,999 Shares at an exercise price of $2.55 per Share, subject to
certain adjustments, and (xix) a common stock purchase warrant (the "Other
Warrant #18", and together with Other Warrant #1, Other Warrant #2, Other
Warrant #3, Other Warrant #4, Other Warrant #5, Other Warrant #6, Other Warrant
#7, Other Warrant #8, Other Warrant #9, Other Warrant #10, Other Warrant #11,
Other Warrant #12, Other Warrant #13, Other Warrant #14, Other Warrant #15,
Other Warrant #16 and Other Warrant #17, the "Other Warrants") to acquire
1,149,436 Shares at an exercise price of $0.01 per Share, subject to certain
adjustments). The January Warrants each contain an issuance limitation
prohibiting the Investors from exercising those securities to the extent that
such exercise would result in beneficial ownership by Erato of more than 9.99%
of the Shares then issued and outstanding (the "9.99% Issuance Limitation"). The
9.99% Issuance Limitation may be waived by the Investors by at least 61 days
notice, provided, however, that such notice shall only be effective if delivered
at a time when no indebtedness of the issuer is outstanding to the holder or its
affiliates and shall become null and void following notice to the issuer upon an
Event of Default (as defined in the relevant instrument). The Other Warrants
each contain an issuance limitation prohibiting the Investors from exercising
those securities to the extent that such exercise would result in beneficial
ownership by the Investors of more than 4.99% of the Shares then issued and
outstanding (the "4.99% Issuance Limitation"). The 4.99% Issuance Limitation may
be waived by the Investors upon at least 61 days prior notice to the Company and
shall automatically become null and void upon the occurrence and/or continuance
of an event of default (as defined in and pursuant to the terms of the
applicable instrument). Erato is a wholly owned subsidiary of the Fund. PSource
and the Fund are managed by Laurus Capital Management, LLC ("LCM"). Valens U.S.
and Valens Offshore are managed by Valens Capital Management, LLC ("VCM").
Eugene Grin and David Grin through other entities are the controlling principals
of LCM and VCM, and share voting and investment power over the securities owned
by the Investors reported in this Schedule 13G.
CUSIP No. 225300201
--------------------------------------------------------------------------------
(1) Names of Reporting Persons. I.R.S. Identification Nos. of Above Persons
(entities only):
Eugene Grin
--------------------------------------------------------------------------------
(2) Check the Appropriate Box if a Member of a Group (See Instructions)
(a) [ ]
(b) [X]
--------------------------------------------------------------------------------
(3) SEC Use Only
--------------------------------------------------------------------------------
(4) Citizenship or Place of Organization: United States
--------------------------------------------------------------------------------
Number of Shares Beneficially Owned
by Each Reporting Person With (5) Sole Voting Power: 0*
--------------------------------------
(6) Shared Voting Power: 3,665,365*
--------------------------------------
(7) Sole Dispositive Power: 0*
--------------------------------------
(8) Shared Dispositive Power: 3,665,365*
--------------------------------------
--------------------------------------------------------------------------------
(9) Aggregate Amount Beneficially Owned by Each Reporting Person:
3,665,365
--------------------------------------------------------------------------------
(10) Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See
Instructions): [X]
--------------------------------------------------------------------------------
(11) Percent of Class Represented by Amount in Row (9): 9.99%
--------------------------------------------------------------------------------
(12) Type of Reporting Person (See Instructions): IN
--------------------------------------------------------------------------------
|
*Based on 36,690,343 shares of the common stock, no par value per share (the
"Shares"), outstanding of Creative Vistas, Inc., an Arizona corporation (the
"Company"), as disclosed to Laurus Master Fund, Ltd. (the "Fund") by the
Company. As of January 23, 2008, the Fund, Erato Corporation ("Erato"), Valens
U.S. SPV I, LLC ("Valens U.S."), Valens Offshore SPV I, Ltd. ("Valens Offshore")
and PSource Structured Debt Limited ("PSource", and together with Erato, the
Fund, Valens U.S. and Valens Offshore, the "Investors", collectively held (i)
3,594,169 Shares, (ii) a common stock purchase warrant (the "January Warrant
#1") to acquire 812,988 Shares at an exercise price of $0.01 per Share, subject
to certain adjustments, (iii) a common stock purchase warrant (the "January
Warrant #2" and together with the January Warrant #1, the "January Warrants") to
acquire 1,738,365 Shares at an exercise price of $0.01 per Share, subject to
certain adjustments, (iv) a common stock purchase warrant (the "Other Warrant
#1") to acquire 108,000 Shares at an exercise price of $0.90 per Share, subject
to certain adjustments, (v) a common stock purchase warrant (the "Other Warrant
#2") to acquire 108,000 Shares at an exercise price of $1.15 per Share, subject
to certain adjustments, (vi) a common stock purchase warrant (the "Other Warrant
#3") to acquire 108,000 Shares at an exercise price of $1.25 per Share, subject
to certain adjustments, (vi) a common stock purchase warrant (the "Other Warrant
#4") to acquire 108,000 Shares at an exercise price of $2.28 per Share, subject
to certain adjustments, (vii) a common stock purchase warrant (the "Other
Warrant #5") to acquire 108,000 Shares at an exercise price of $2.10 per Share,
subject to certain adjustments, (viii) a common stock purchase warrant (the
"Other Warrant #6") to acquire 108,000 Shares at an exercise price of $2.55 per
Share, subject to certain adjustments, (ix) a common stock purchase warrant (the
"Other Warrant #7") to acquire 108,000 Shares at an exercise price of $2.73 per
Share, subject to certain adjustments, (x) a common stock purchase warrant (the
"Other Warrant #8") to acquire 108,000 Shares at an exercise price of $2.43 per
Share, subject to certain adjustments, (xi) a common stock purchase warrant (the
"Other Warrant #9") to acquire 139,800 Shares at an exercise price of $0.0067
per Share, subject to certain adjustments, (xii) a common stock purchase warrant
(the "Other Warrant #10") to acquire 1,094,636 Shares at an exercise price of
$1.15 per Share, subject to certain adjustments, (xiii) a common stock purchase
warrant (the "Other Warrant #11") to acquire 100,000 Shares at an exercise price
of $1.20 per Share, subject to certain adjustments, (xiv) a common stock
purchase warrant (the "Other Warrant #12") to acquire 100,000 Shares at an
exercise price of $1.01 per Share, subject to certain adjustments, (xv) a common
stock purchase warrant (the "Other Warrant #13") to acquire 313,000 Shares at an
exercise price of $1.00 per Share, subject to certain adjustments, (xvi) a
common stock purchase warrant (the "Other Warrant #15") to acquire 100,000
Shares at an exercise price of $0.90 per Share, subject to certain adjustments,
(xvii) a common stock purchase warrant (the "Other Warrant #16") to acquire
107,999 Shares at an exercise price of $2.60 per Share, subject to certain
adjustments, (xviii) a common stock purchase warrant (the "Other Warrant #17")
to acquire 107,999 Shares at an exercise price of $2.55 per Share, subject to
certain adjustments, and (xix) a common stock purchase warrant (the "Other
Warrant #18", and together with Other Warrant #1, Other Warrant #2, Other
Warrant #3, Other Warrant #4, Other Warrant #5, Other Warrant #6, Other Warrant
#7, Other Warrant #8, Other Warrant #9, Other Warrant #10, Other Warrant #11,
Other Warrant #12, Other Warrant #13, Other Warrant #14, Other Warrant #15,
Other Warrant #16 and Other Warrant #17, the "Other Warrants") to acquire
1,149,436 Shares at an exercise price of $0.01 per Share, subject to certain
adjustments). The January Warrants each contain an issuance limitation
prohibiting the Investors from exercising those securities to the extent that
such exercise would result in beneficial ownership by Erato of more than 9.99%
of the Shares then issued and outstanding (the "9.99% Issuance Limitation"). The
9.99% Issuance Limitation may be waived by the Investors by at least 61 days
notice, provided, however, that such notice shall only be effective if delivered
at a time when no indebtedness of the issuer is outstanding to the holder or its
affiliates and shall become null and void following notice to the issuer upon an
Event of Default (as defined in the relevant instrument). The Other Warrants
each contain an issuance limitation prohibiting the Investors from exercising
those securities to the extent that such exercise would result in beneficial
ownership by the Investors of more than 4.99% of the Shares then issued and
outstanding (the "4.99% Issuance Limitation"). The 4.99% Issuance Limitation may
be waived by the Investors upon at least 61 days prior notice to the Company and
shall automatically become null and void upon the occurrence and/or continuance
of an event of default (as defined in and pursuant to the terms of the
applicable instrument). Erato is a wholly owned subsidiary of the Fund. PSource
and the Fund are managed by Laurus Capital Management, LLC ("LCM"). Valens U.S.
and Valens Offshore are managed by Valens Capital Management, LLC ("VCM").
Eugene Grin and David Grin through other entities are the controlling principals
of LCM and VCM, and share voting and investment power over the securities owned
by the Investors reported in this Schedule 13G.
CUSIP No. 225300201
Item 1(a). Name Of Issuer: Creative Vistas, Inc.
Item 1(b). Address of Issuer's Principal Executive Offices:
4909 East McDowell Road, Phoenix, Arizona 85008
Item 2(a). Name of Person Filing: Laurus Master Fund, Ltd.
This Schedule 13G is also filed on behalf of Erato Corporation, a
Delaware corporation, PSource Structured Debt Limited, a closed-ended
company incorporated with limited liability in Guernsey, Laurus
Capital Management, LLC, a Delaware limited liability company, Valens
U.S. SPV I, LLC, a Delaware limited liability company, Valens Offshore
SPV I, Ltd., a Cayman Islands limited company, Valens Capital
Management, LLC, a Delaware limited liability company, Eugene Grin and
David Grin. Erato Corporation is a wholly owned subsidiary of Laurus
Master Fund, Ltd. Laurus Capital Management, LLC manages Laurus Master
Fund, Ltd and PSource Structured Debt Limited. Valens Capital
Management, LLC manages Valens U.S. SPV I, LLC and Valens Offshore SPV
I, Ltd. Eugene Grin and David Grin, through other entities, are the
controlling principals of Laurus Capital Management, LLC and Valens
Capital Management, LLC and share voting and investment power over the
securities owned by Erato Corporation, PSource Structured Debt
Limited, Valens U.S. SPV I, LLC, and Valens Offshore SPV I, Ltd. as
reported in this Schedule 13G. Information related to each of Erato
Corporation, PSource Structured Debt Limited, Valens U.S. SPV I, LLC,
Valens Offshore SPV I, Ltd., Laurus Capital Management, LLC, Valens
Capital Management, LLC, Eugene Grin and David Grin is set forth on
Appendix A hereto.
Item 2(b). Address of Principal Business Office or, if None, Residence:
c/o Laurus Capital Management, LLC
335 Madison Avenue, 10th Floor, New York, NY 10017
Item 2(c). Citizenship:
Cayman Islands
Item 2(d). Title of Class of Securities: Common Stock, no par value per share
("Common Stock")
Item 2(e). CUSIP No.: 225300201
Item 3. If This Statement Is Filed Pursuant to Sections 240.13d-1(b) or
240.13d-2(b) or (c), check whether the Person Filing is a:
Not Applicable.
Item 4. Ownership
(a) Amount Beneficially Owned: 3,665,365
(b) Percent of Class: 9.99%
(c) Number of Shares as to which the person has:
(i) sole power to vote or to direct the vote 0*
(ii) shared power to vote or to direct the vote 3,665,365*
(iii) sole power to dispose or to direct the
disposition of 0*
(iv) shared power to dispose or to direct the
disposition of 3,665,365*
-------------------
|
*Based on 36,690,343 shares of the common stock, no par value per share (the
"Shares"), outstanding of Creative Vistas, Inc., an Arizona corporation (the
"Company"), as disclosed to Laurus Master Fund, Ltd. (the "Fund") by the
Company. As of January 23, 2008, the Fund, Erato Corporation ("Erato"), Valens
U.S. SPV I, LLC ("Valens U.S."), Valens Offshore SPV I, Ltd. ("Valens Offshore")
and PSource Structured Debt Limited ("PSource", and together with Erato, the
Fund, Valens U.S. and Valens Offshore, the "Investors", collectively held (i)
3,594,169 Shares, (ii) a common stock purchase warrant (the "January Warrant
#1") to acquire 812,988 Shares at an exercise price of $0.01 per Share, subject
to certain adjustments, (iii) a common stock purchase warrant (the "January
Warrant #2" and together with the January Warrant #1, the "January Warrants") to
acquire 1,738,365 Shares at an exercise price of $0.01 per Share, subject to
certain adjustments, (iv) a common stock purchase warrant (the "Other Warrant
#1") to acquire 108,000 Shares at an exercise price of $0.90 per Share, subject
to certain adjustments, (v) a common stock purchase warrant (the "Other Warrant
#2") to acquire 108,000 Shares at an exercise price of $1.15 per Share, subject
to certain adjustments, (vi) a common stock purchase warrant (the "Other Warrant
#3") to acquire 108,000 Shares at an exercise price of $1.25 per Share, subject
to certain adjustments, (vi) a common stock purchase warrant (the "Other Warrant
#4") to acquire 108,000 Shares at an exercise price of $2.28 per Share, subject
to certain adjustments, (vii) a common stock purchase warrant (the "Other
Warrant #5") to acquire 108,000 Shares at an exercise price of $2.10 per Share,
subject to certain adjustments, (viii) a common stock purchase warrant (the
"Other Warrant #6") to acquire 108,000 Shares at an exercise price of $2.55 per
Share, subject to certain adjustments, (ix) a common stock purchase warrant (the
"Other Warrant #7") to acquire 108,000 Shares at an exercise price of $2.73 per
Share, subject to certain adjustments, (x) a common stock purchase warrant (the
"Other Warrant #8") to acquire 108,000 Shares at an exercise price of $2.43 per
Share, subject to certain adjustments, (xi) a common stock purchase warrant (the
"Other Warrant #9") to acquire 139,800 Shares at an exercise price of $0.0067
per Share, subject to certain adjustments, (xii) a common stock purchase warrant
(the "Other Warrant #10") to acquire 1,094,636 Shares at an exercise price of
$1.15 per Share, subject to certain adjustments, (xiii) a common stock purchase
warrant (the "Other Warrant #11") to acquire 100,000 Shares at an exercise price
of $1.20 per Share, subject to certain adjustments, (xiv) a common stock
purchase warrant (the "Other Warrant #12") to acquire 100,000 Shares at an
exercise price of $1.01 per Share, subject to certain adjustments, (xv) a common
stock purchase warrant (the "Other Warrant #13") to acquire 313,000 Shares at an
exercise price of $1.00 per Share, subject to certain adjustments, (xvi) a
common stock purchase warrant (the "Other Warrant #15") to acquire 100,000
Shares at an exercise price of $0.90 per Share, subject to certain adjustments,
(xvii) a common stock purchase warrant (the "Other Warrant #16") to acquire
107,999 Shares at an exercise price of $2.60 per Share, subject to certain
adjustments, (xviii) a common stock purchase warrant (the "Other Warrant #17")
to acquire 107,999 Shares at an exercise price of $2.55 per Share, subject to
certain adjustments, and (xix) a common stock purchase warrant (the "Other
Warrant #18", and together with Other Warrant #1, Other Warrant #2, Other
Warrant #3, Other Warrant #4, Other Warrant #5, Other Warrant #6, Other Warrant
#7, Other Warrant #8, Other Warrant #9, Other Warrant #10, Other Warrant #11,
Other Warrant #12, Other Warrant #13, Other Warrant #14, Other Warrant #15,
Other Warrant #16 and Other Warrant #17, the "Other Warrants") to acquire
1,149,436 Shares at an exercise price of $0.01 per Share, subject to certain
adjustments). The January Warrants each contain an issuance limitation
prohibiting the Investors from exercising those securities to the extent that
such exercise would result in beneficial ownership by Erato of more than 9.99%
of the Shares then issued and outstanding (the "9.99% Issuance Limitation"). The
9.99% Issuance Limitation may be waived by the Investors by at least 61 days
notice, provided, however, that such notice shall only be effective if delivered
at a time when no indebtedness of the issuer is outstanding to the holder or its
affiliates and shall become null and void following notice to the issuer upon an
Event of Default (as defined in the relevant instrument). The Other Warrants
each contain an issuance limitation prohibiting the Investors from exercising
those securities to the extent that such exercise would result in beneficial
ownership by the Investors of more than 4.99% of the Shares then issued and
outstanding (the "4.99% Issuance Limitation"). The 4.99% Issuance Limitation may
be waived by the Investors upon at least 61 days prior notice to the Company and
shall automatically become null and void upon the occurrence and/or continuance
of an event of default (as defined in and pursuant to the terms of the
applicable instrument). Erato is a wholly owned subsidiary of the Fund. PSource
and the Fund are managed by Laurus Capital Management, LLC ("LCM"). Valens U.S.
and Valens Offshore are managed by Valens Capital Management, LLC ("VCM").
Eugene Grin and David Grin through other entities are the controlling principals
of LCM and VCM, and share voting and investment power over the securities owned
by the Investors reported in this Schedule 13G.
Item 5. Ownership of Five Percent or Less of a Class
Not applicable
Item 6. Ownership of More Than Five Percent on Behalf of Another Person
Not Applicable.
Item 7. Identification and Classification of the Subsidiary Which Acquired
the Security Being Reported on by the Parent Holding Company or Control
Person
Not Applicable.
Item 8. Identification and Classification of Members of the Group
Not Applicable.
Item 9. Notice of Dissolution of Group
Not Applicable.
Item 10. Certification
By signing below I certify that, to the best of my knowledge and
belief, the securities referred to above were not acquired and are not held for
the purpose of or with the effect of changing or influencing the control of the
issuer of the securities and were not acquired and are not held in connection
with or as a participant in any transaction having that purpose or effect.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief,
I certify that the information set forth in this statement is true, complete and
correct.
February 6, 2008
Date
LAURUS MASTER FUND, LTD.
By: /s/ Eugene Grin
-------------------------------
Name: Eugene Grin
Title: Principal
|
Attention: Intentional misstatements or omissions of fact constitute
Federal criminal violations (See 18 U.S.C. 1001)
CUSIP No. 225300201
APPENDIX A
A. Name: Erato Corporation, a Delaware corporation
Address: 335 Madison Avenue, 10th Floor
New York, New York 10017
Place of
Organization: Delaware
B. Name: PSource Structured Debt Limited, a closed-ended
company incorporated with limited liability in
Guernsey
Address: 335 Madison Avenue, 10th Floor
New York, New York 10017
Place of
Organization: Guernsey
C. Name: Laurus Capital Management, LLC, a Delaware
limited liability company
Address: 335 Madison Avenue, 10th Floor
New York, New York 10017
Place of
Organization: Delaware
D. Name: Valens U.S. SPV I, LLC, a Delaware limited
liability company
Address: 335 Madison Avenue, 10th Floor
New York, New York 10017
Place of
Organization: Delaware
E. Name: Valens Offshore SPV I Ltd., a Cayman Islands
limited company
Address: 335 Madison Avenue, 10th Floor
New York, New York 10017
Place of
Organization: Cayman Islands
F. Name: Valens Capital Management, LLC, a Delaware limited
liability company
Address: 335 Madison Avenue, 10th Floor
New York, New York 10017
Place of
Organization: Delaware
G. Name: David Grin
Business 335 Madison Avenue, 10th Floor
Address: New York, New York 10017
Principal Director of Laurus Master Fund, Ltd.
Occupation: Principal of Laurus Capital Management, LLC
Citizenship: Israel
H. Name: Eugene Grin
Business 335 Madison Avenue, 10th Floor
Address: New York, New York 10017
Principal Director of Laurus Master Fund, Ltd.
Occupation: Principal of Laurus Capital Management, LLC
Citizenship: United States
|
CUSIP No. 225300201
Each of Erato Corporation, PSource Structured Debt Limited, Valens U.S. SPV I,
LLC, Valens Offshore SPV I, Ltd., Valens Capital Management, LLC, Laurus Capital
Management, LLC, David Grin and Eugene Grin hereby agree, by their execution
below, that the Schedule 13G to which this Appendix A is attached is filed on
behalf of each of them, respectively.
Laurus Capital Management, LLC,
PSource Structured Debt Limited
Erato Corporation
By Laurus Capital Management, LLC,
individually and as investment manager
/s/ Eugene Grin
-----------------------------------------
Eugene Grin
Authorized Signatory
February 6, 2008
Valens U.S. SPV I, LLC
Valens Offshore SPV I, Ltd.,
Valens Capital Management, LLC
By: Valens Capital Management, LLC
Individually and as investment manager
/s/ Eugene Grin
-----------------------------------------
Eugene Grin
Authorized Signatory
February 6, 2008
/s/ David Grin
-----------------------------------------
David Grin
February 6, 2008
/s/ Eugene Grin
-----------------------------------------
Eugene Grin
February 6, 2008
|
Grafico Azioni Creative Vistas (CE) (USOTC:CVAS)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni Creative Vistas (CE) (USOTC:CVAS)
Storico
Da Giu 2023 a Giu 2024
